Inogen (Inogen) Intangible Assets

: $44.6 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Inogen's intangible assets for the quarter that ended in Dec. 2023 was $44.6 Mil.

Inogen Intangible Assets Historical Data

The historical data trend for Inogen's Intangible Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inogen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Intangible Assets

110.49

101.96

93.13

33.03

44.65

Inogen Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Intangible Assets																33.03	32.89	32.89	43.94	44.65

Inogen Intangible Assets Calculation

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Examples of intangible assets include trade secrets, copyrights, patents, trademarks. If a company acquires assets at the prices above the book value, it may carry goodwill on its balance sheet. Goodwill reflects the difference between the price the company paid and the book value of the assets.

Inogen (NAS:INGN) Intangible Assets Explanation

If a company (company A) received a patent through their own work, though it has value, it does not show up on its balance sheet as an intangible asset. However, if company A sells this patent to company B, it will show up on company B's balance sheet as an intangible asset.

The same applies to brand names, trade secrets etc. For instance, Coca-Cola's brand is extremely valuable, but the brand does not appear on its balance sheet, because the brand was never acquired.

Some intangibles are amortized. Amortization is the depreciation of intangible assets.

Many intangibles are not amortized. They may still be written down when the company decides the asset is impaired.

Whenever you see an increase in goodwill over a number of years, you can assume it's because the company is out buying other businesses above book value. GOOD if buying businesses with durable competitive advantage.

If goodwill stays the same, the company when acquiring other companies is either paying less than book value or not acquiring. Businesses with moats never sell for less than book value.

Intangibles acquired are on balance sheet at fair value.

Internally developed brand names (Coke, Wrigleys, Band-Aid) however are not reflected on the balance sheet.

One of the reasons competitive advantage power can remain hidden for so long.

Be Aware

Companies may change the way intangible assets are amortized, and this will affect their reported earnings.

Inogen Intangible Assets Related Terms

Thank you for viewing the detailed overview of Inogen's Intangible Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Inogen (Inogen) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inogen Inc (NAS:INGN) » Definitions » Intangible Assets

Comparable Companies

Traded in Other Exchanges

6IO:Germany

Address

301 Coromar Drive, Goleta, CA, USA, 93117

Website

https://www.inogen.com

Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, Inogen sells its products through distributors or large gas companies and home oxygen providers. Inogen generates the majority of its revenue in the United States.

Executives

Thomas A. West	director	C/O INTERSECT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025
Stanislav Glezer	officer: EVP, Chief Medical Officer	C/O INOGEN, INC., 326 BOLLAY DRIVE., GOLETA CA 93117
Jason Somer	officer: EVP, Gen. Counsel & Secretary	C/O INOGEN, INC., 301 COROMAR DRIVE, GOLETA CA 93117
Glenn S Boehnlein	director	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Mary Kay Ladone	director	130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601
Kevin M King	director	C/O AFFYMETRIX, INC., 3420 CENTRAL EXPRESSWAY, SANTA CLARA CA 95051
Kristin A. Caltrider	officer: EVP, CFO and Treasurer	C/O INOGEN, INC., 301 COROMAR DRIVE, GOLETA CA 93117
Anderson Ray Benjamin M	director	1100 NORTH WASHINGTON STREET, DELPHI IN 46923
Michael K. Sergesketter	officer: EVP, CFO and Treasurer	301 COROMAR DRIVE, GOLETA CA 93117
Raymond Huggenberger	director, officer: See Remarks	326 BOLLAY DRIVE, GOLETA CA 93117
Alison Bauerlein	officer: See Remarks	326 BOLLAY DRIVE, GOLETA CA 93117
Brenton Taylor	officer: Vice President, Engineering	326 BOLLAY DRIVE, GOLETA CA 93117
Elizabeth Mora	director	C/O MKS INSTRUMENTS, INC., 2 TECH DRIVE, SUITE 201, ANDOVER MA 01810
George J Parr	director	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Byron Myers	officer: Vice President, Marketing	326 BOLLAY DRIVE, GOLETA CA 93117